medi | Evaluate

October 03, 2016

Allergan shows it has stomach for more GI dealmaking

Celgene pays through the nose for a hand in immune checkpoints

May 03, 2016

Regeneron nips at Amgen and Pfizer’s heels in pain drug race

December 22, 2015

Therapy focus – How do you solve a problem like CAR-T relapse?

April 24, 2015

Celgene signals bigger immuno-oncology push into blood cancers

March 24, 2015

Tanezumab’s return shows pharma has held its nerve

June 19, 2014

Astra makes quiet progress with respiratory pipeline

May 12, 2014

Astra’s brodalumab hit is perfectly timed

May 07, 2014

Don’t blame Soriot, he’s just doing his job

January 14, 2014

Merck catches Bristol with surprise PD-1 filing

November 07, 2013

Lilly deal hints at renewed interest in once promising pain class

Load More